S. Hossein Fatemi, MD, PhD

Professor, Department of Psychiatry

S. Hossein Fatemi

Contact Info

fatem002@umn.edu

Office Phone 612-626-3633

Office Address:
392 MMC

Administrative Assistant Name
Viv Engel

Administrative Phone
612-273-9801

Administrative Email
engel749@umn.edu

Administrative Fax Number
612-273-9779

MD, Case Western Reserve University

Residency, Psychiatry, University Hospitals, Cleveland, OH

PhD, Anatomy, University of Nebraska Medical Center

MS, Anatomy, University of Nebraska Medical Center

BS, Biology, Baylor University

Internship, Diagnostic Radiology at University of Cincinnati Hospital, 1991-1992

Summary

Dr. Fatemi is a Professor of Psychiatry and Neuroscience and the Bernstein Endowed Chair in Adult Psychiatry at the University of Minnesota Medical School. Dr. Fatemi’s research has focused on the biological basis of neurodevelopmental disorders, primarily autism and schizophrenia. His clinical interest has focused on the treatment of schizophrenia, bipolar disorder, and major depression. He has over 20 years of experience in research and treatment of major psychiatric disorders. Dr. Fatemi is an Elected Fellow of the American College of Psychiatrists, an Elected Fellow of the American College of Neuropsychopharmacology, and a Fellow of the Collegium Internationale Neuropsychopharmacologicum.

Professional Associations

  • Associate Chair for Neuroscience and Translational Research

Research

Research Summary/Interests

Dr. Fatemi's research focuses on the neurodevelopmental mechanisms that contribute to normal structure and function of the brain and which, under certain circumstances, cause neuropsychiatric disorders. His research has been conducted on two levels: one at the level of human brain dysfunction (postmortem studies involving schizophrenic, depressed, bipolar, and autistic patients) and secondly on development of an animal model to mimic schizophrenia and autism (prenatal viral infection in mice). Dr. Fatemi has also investigated the effects of various psychotropic agents, e.g., olanzapine, clozapine, fluoxetine, valproic acid, haloperidol, and lithium, on expression of genes of interest in rats following chronic administration of each drug. The ultimate goals of Dr. Fatemi’s research are to better understand the genesis of these disabling disorders and to treat patients afflicted by them. Dr. Fatemi’s research has been funded by multiple grants from the National Institutes of Health, the Stanley Medical Research Institute, the National Alliance for Research in Schizophrenia and Depression, and the Minnesota Medical Foundation. His research has been published in top journals including Molecular Psychiatry, Synapse, Molecular Autism, and Translational Psychiatry. Dr. Fatemi has published 121 articles, 33 book chapters, and edited five books. Dr. Fatemi is an Associate Editor of Cerebellum and Ataxias, a Regional Editor (USA) for Central Nervous System Agents in Medicinal Chemistry, and on the editorial boards of multiple journals including Molecular Psychiatry, PLoS One and Pharmacopsychiatry.

Publications

For a list of publications, see PubMed.

Clinical

Board Certifications

  • Adult psychiatry, Diplomate of American Board of Psychiatry and Neurology
  • Psychosomatic medicine, Diplomate of American Board of Psychiatry and Neurology